This Form 3 is a routine compliance filing with no trading signal. Monitor for the upcoming IPO pricing and subsequent lockup expiry details to gauge potential selling pressure from these pre-IPO holders.
Price Chart
Executive Summary
This is a routine initial statement of beneficial ownership (Form 3) filed by 5AM Ventures VI, L.P., 5AM Partners VI, LLC, 5AM Opportunities II, L.P., 5AM Opportunities II (GP), LLC, and individuals Kush Parmar and Andrew J. Schwab upon Latigo Biotherapeutics becoming subject to Section 16 reporting obligations, likely ahead of its IPO. The filing discloses that the 5AM funds collectively hold shares of Series A, Series A-2, and Series B Preferred Stock, each convertible into Common Stock on a one-for-one basis, with no immediate trading signal.
Key Facts
- 5AM Ventures VI and 5AM Opportunities II report beneficial ownership via their respective general partners and managing members.
- Series A Preferred Stock (convertible into 3,152,305 shares of Common Stock) is held by 5AM Ventures VI.
- Series A-2 Preferred Stock (convertible into 1,823,238 shares of Common Stock) is held by 5AM Ventures VI.
- Series A-2 Preferred Stock (convertible into 866,018 shares of Common Stock) is held by 5AM Opportunities II.
- Series B Preferred Stock (convertible into 1,484,401 shares of Common Stock) is held by 5AM Opportunities II.
- All preferred shares are convertible into Common Stock on a one-for-one basis at the option of the holder and will convert automatically upon closing of the Issuer's initial public offering.
- Reporting individuals and entities disclaim beneficial ownership except for their pecuniary interest.
Financial Impact
No financial impact; this is a disclosure filing for insider holdings.
Risk Factors
- Preferred-to-common conversion upon IPO will significantly dilute public float, though pre-IPO holders are typically subject to lockup.
- Concentration of ownership by 5AM funds could lead to post-lockup selling pressure.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001231919-26-000841 |
| Document: 0001231919-26-000841-index.html | 0001231919-26-000841 |
| Document: 0001231919-26-000841.txt | 0001231919-26-000841 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $23.04 $23.73 | ▲ +2.99% | ▲ +3.54% | $15.26 (−33.77%) |
Aug 12, 2026 10w ago | 3 | $19.38 $20.06 | ▲ +3.54% | ▲ +2.84% | $15.26 (−21.24%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 10, 2026 11w ago | 8-K | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.26 (−17.60%) |
Aug 7, 2026 11w ago | EFFECT | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.26 (−16.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers